BlackRock Japan’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$15K Buy
2,069
+365
+21% +$2.63K ﹤0.01% 1175
2016
Q3
$10K Buy
+1,704
New +$8.05K ﹤0.01% 1209
2016
Q2
Sell
-5,986
Closed -$15K 1513
2016
Q1
$15K Buy
5,986
+3,834
+178% +$14K ﹤0.01% 1231
2015
Q4
$17K Buy
+2,152
New +$15.2K ﹤0.01% 1196
2013
Q4
Sell
-4,204
Closed -$23K 1432
2013
Q3
$23K Sell
4,204
-2,885
-41% -$31.2K ﹤0.01% 1218
2013
Q2
$100K Buy
+7,089
New +$91.9K ﹤0.01% 978

Other funds holding CCXI

BlackRock Japan's CCXI Position: Q4 2016 in Review

BlackRock Japan increased its ChemoCentryx, Inc. (CCXI) stake by 21% in Q4 2016, buying an estimated $2.63K and bringing the position to 2,069 shares worth $15K. The position accounts for ﹤0.01% of the portfolio, ranked #1175.

BlackRock Japan first reported a position in CCXI in Q2 2013 and has held it in 6 quarters since. The position peaked at $100K in Q2 2013. 89 funds tracked by Wall St. Rank hold CCXI as of Q4 2016.

  • BlackRock Japan held 2,069 shares of ChemoCentryx, Inc. worth $15K as of Q4 2016.
  • BlackRock Japan bought 365 ChemoCentryx, Inc. shares in Q4 2016, an estimated $2.63K.
  • ChemoCentryx, Inc. made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1175 holding.
  • BlackRock Japan first reported a position in ChemoCentryx, Inc. in Q2 2013 and has held it in 6 quarters since.
  • BlackRock Japan's ChemoCentryx, Inc. position peaked at $100K in Q2 2013.
  • 89 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.